Search PubMed⌕ Search

PubMed · 11116837

[In Process Citation]

Abstract

The impingement syndrome is a common disorder of the||| shoulder girdle. The causes for this syndrome may be anatomic changes in the||| coracoacromial arch, also within the ultrastructural regions, on the one hand,||| or changes in the biomechanics which have developed for various reasons, on the||| other. Diagnosis is based on roentgenograms using the appropriate technique. In||| large-scale-studies, sonography has proved to be an extremely sensitive||| screening method for differential diagnosis of rupture of the rotator cuff.||| Magnetic resonance imaging might gain in value in the diagnosis of impingement||| as regards differential diagnosis of rupture of the rotator cuff because this||| technique--when employed appropriately--allows exact viewing of the soft tissue||| and the anterior part of the acromion. In the majority of cases conservative||| treatment is the method of choice. Methods of treatment are sonography,||| galvanization, and application of heat. Physiotherapy should not be initiated||| until pain relief has been achieved by other measures. Infiltration therapy is||| of considerable value in the management of pain due to impingement. Application||| of cortisone into the subacromial space must also be considered critically. As||| regards conservative therapy, only few evidence-based publications provide||| information on the effectiveness of different treatment regimens. Surgical||| therapy is only indicated in cases of pain resistant to the conservative||| therapy for a certain period. Furthermore, only an outlet impingement can be||| treated successfully by surgical decompression. The surgeon decides on the||| surgical method--open surgery or arthroscopy. Of course, arthroscopic methods||| are less invasive; however, up to now the superiority of one of the surgical||| methods over the other could not yet be proven by mid-term clinical results.||| Other surgical methods such as wedge osteotomy in the region of the spina||| scapulae are still in the experimental stage. By surgical and conservatives||| methods, good and even excellent results can be achieved in about 80% of the||| cases. The question remains as to why 20% of the patients show unsatisfactory||| results. One explanation might be that factors such as pathologic changes of||| the muscular balance and an altered microstructure of the tendons of the||| rotator cuff are rarely taken into consideration and Neer's concept of||| decompression is overestimated. Further research will be required in the field||| of biomechanics but clinical research on treatment concepts should also be||| undertaken to develop more differentiated strategies of||| treatment.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C Wurnig. 2000. [In Process Citation]. https://pubmed.ncbi.nlm.nih.gov/11116837/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗